Market Cap: $406.35M
Filed a patent for "high concentration formulations for anti-insulin receptor antibody and uses thereof" on Thu, August 24, 2023
Filed a patent for "solid dosage forms of a plasma kallikrein inhibitor" on Tue, November 22, 2022
Filed a patent for "inhibitors of plasma kallikrein" on Tue, April 18, 2023
Filed a patent for "inhibitors of plasma kallikrein" on Fri, July 29, 2022
